ALVARO GONZALEZ: Open Payments
NPI 1821106964 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,019 in 142 payments from 22 companies in 2025. Trend: 2023 $1,505 · 2024 $2,594 · 2025 $3,019
Food & beverage: $2,357Consulting: $500Education: $163
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 4 | $533 |
| Incyte Corporation | 29 | $402 |
| Janssen Biotech, Inc. | 15 | $276 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $231 |
| UCB, Inc. | 11 | $229 |
| Novartis Pharmaceuticals Corporation | 12 | $200 |
| Regeneron Healthcare Solutions, Inc. | 6 | $198 |
| Lilly USA, LLC | 8 | $165 |
| Arcutis Biotherapeutics, Inc. | 10 | $164 |
| Galderma Laboratories, L.P. | 14 | $160 |
Products named: OPZELURA, TREMFYA, Bimzelx, DUPIXENT, ILUMYA, TALTZ, Zoryve, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
